Unknown

Dataset Information

A new genetic locus for antipsychotic-induced weight gain: A genome-wide study of first-episode psychosis patients using amisulpride (from the OPTiMiSE cohort).


ABSTRACT:

Background

Antipsychotic-induced weight gain is a common and debilitating side effect of antipsychotics. Although genome-wide association studies of antipsychotic-induced weight gain have been performed, few genome-wide loci have been discovered. Moreover, these genome-wide association studies have included a wide variety of antipsychotic compounds.

Aims

We aim to gain more insight in the genomic loci affecting antipsychotic-induced weight gain. Given the variable pharmacological properties of antipsychotics, we hypothesized that targeting a single antipsychotic compound would provide new clues about genomic loci affecting antipsychotic-induced weight gain.

Methods

All subjects included for this genome-wide association study (n=339) were first-episode schizophr

SUBMITTER: Ter Hark SE 

PROVIDER: S-EPMC7222287 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature